ArticleJournal of thrombosis and thrombolysis2023

Comparison of 4-factor prothrombin complex concentrate and andexanet alfa for reversal of apixaban and rivaroxaban in the setting of intracranial hemorrhage.

Michelle Lipski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.